S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Peace, music and memories: As the 1960s fade, historians scramble to capture Woodstock's voices
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
In Senegal's capital, Nicaragua is a hot ticket among travel agents as migrants try to reach US
California authorizes expansion of Waymo's driverless car services to LA, SF peninsula
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
College athletes will need school approval for NIL deals under bill passed by Utah Legislature

Inventiva (IVA) News Today

$4.04
+0.42 (+11.59%)
(As of 03/1/2024 ET)
SourceHeadline
MarketBeat logoInventiva S.A. (NASDAQ:IVA) Receives Average Recommendation of "Buy" from Analysts
americanbankingnews.com - February 29 at 6:12 AM
MarketBeat logoInventiva S.A. (NASDAQ:IVA) Expected to Earn FY2023 Earnings of ($2.26) Per Share
americanbankingnews.com - February 24 at 1:24 AM
marketbeat.com logoInventiva S.A. (NASDAQ:IVA) to Post FY2023 Earnings of ($2.26) Per Share, HC Wainwright Forecasts
marketbeat.com - February 23 at 6:34 AM
markets.businessinsider.com logoBuy Rating for Inventiva Despite Temporary Trial Setback: Analyst Sees Isolated Incident and Strong Safety Record
markets.businessinsider.com - February 17 at 7:54 PM
msn.com logoInventiva halt recruitment for Phase III NASH trial following adverse event
msn.com - February 16 at 2:03 PM
marketbeat.com logoStifel Nicolaus Cuts Inventiva (NASDAQ:IVA) Price Target to $25.00
marketbeat.com - February 16 at 10:49 AM
marketwatch.com logoInventiva Stock Falls 20% After Pausing Screening, Randomization in Trial Due to Adverse Event
marketwatch.com - February 16 at 9:03 AM
finanznachrichten.de logoINVENTIVA: Inventiva reports preliminary 2023 fiscal year financial Information and provides an update on its clinical trial NATiV3
finanznachrichten.de - February 15 at 6:00 PM
finance.yahoo.com logoInventiva reports preliminary 2023 fiscal year financial Information¹ and provides an update on its clinical trial NATiV3
finance.yahoo.com - February 15 at 6:00 PM
globenewswire.com logoInventiva reports preliminary 2023 fiscal year financial Information¹ and provides an update on its clinical trial NATiV3
globenewswire.com - February 15 at 4:35 PM
msn.com logo11 of the Best Investing Books for Beginners
msn.com - February 6 at 5:47 PM
marketbeat.com logoInventiva S.A. (NASDAQ:IVA) Receives Consensus Rating of "Buy" from Brokerages
marketbeat.com - February 4 at 5:10 AM
msn.com logoFDA accepts Adaptimmune BLA for afami-cel, decision expected by Aug. 4
msn.com - January 31 at 9:47 PM
morningstar.com logoInventiva SA ADR IVA
morningstar.com - January 31 at 5:48 PM
markets.businessinsider.com logoHalf-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
markets.businessinsider.com - January 24 at 8:07 PM
finanznachrichten.de logoINVENTIVA: Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux
finanznachrichten.de - January 24 at 5:07 PM
finance.yahoo.com logoNon-Alcoholic Steatohepatitis Treatment Drug Market In Japan is Expected to Showcase Impressive Growth by 2032 | DelveInsight
finance.yahoo.com - January 17 at 5:48 PM
marketbeat.com logoInventiva S.A. (NASDAQ:IVA) Short Interest Update
marketbeat.com - January 17 at 6:18 AM
finanznachrichten.de logoINVENTIVA: Inventiva draws down the second tranche of €25 million under existing Finance Contract with the European Investment Bank
finanznachrichten.de - January 10 at 7:29 PM
marketbeat.com logoInventiva (NASDAQ:IVA) Earns "Outperform" Rating from Lifesci Capital
marketbeat.com - January 9 at 8:31 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Annexon Biosciences (ANNX)
markets.businessinsider.com - December 21 at 11:01 PM
marketbeat.com logoInventiva (NASDAQ:IVA) Price Target Lowered to $24.00 at HC Wainwright
marketbeat.com - December 21 at 8:22 AM
finance.yahoo.com logoInventiva announces the randomization of the first patient in China in the NATiV3 clinical trial and provides an update on its clinical development program
finance.yahoo.com - December 20 at 7:26 PM
marketbeat.com logoInventiva S.A. (NASDAQ:IVA) Sees Large Decline in Short Interest
marketbeat.com - December 17 at 2:56 PM
marketbeat.com logoInventiva S.A. (NASDAQ:IVA) Receives Consensus Recommendation of "Buy" from Analysts
marketbeat.com - December 16 at 6:43 AM
msn.com logoSEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials
msn.com - December 15 at 7:35 PM
finance.yahoo.com logoInventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH
finance.yahoo.com - December 4 at 8:24 PM
markets.businessinsider.com logoAnalysts’ Top Healthcare Picks: Morphosys Ag (MOR), Abbott Labs (ABT)
markets.businessinsider.com - November 22 at 10:12 PM
finanznachrichten.de logoINVENTIVA: Inventiva reports 2023 Third Quarter Financial Information
finanznachrichten.de - November 21 at 8:14 PM
msn.com logoInventiva reports 9M results
msn.com - November 21 at 8:14 PM
finance.yahoo.com logoInventiva reports 2023 Third Quarter Financial Information¹
finance.yahoo.com - November 21 at 4:10 PM
lse.co.uk logoInventiva Share Price (IVA.PA)
lse.co.uk - November 12 at 1:44 PM
markets.businessinsider.com logoHold Rating on Madrigal Pharmaceuticals Amid Potential and Uncertainties: FDA Review, Commercial Launch, and Mixed Data Impact
markets.businessinsider.com - November 9 at 10:15 AM
finance.yahoo.com logoInventiva announces a late breaker abstract and two additional abstracts on its lead compound, lanifibranor, at the AASLD The Liver Meeting® 2023
finance.yahoo.com - November 6 at 6:25 PM
finance.yahoo.com logoNon-alcoholic Steatohepatitis Market to grow by USD 11.22 billion from 2022 to 2027, North America to account for 51% of market growth- Technavio
finance.yahoo.com - October 27 at 7:17 PM
markets.businessinsider.com logoPositive Prospects for Inventiva: Pivotal NATiV3 Trial Progress, Anticipated LEGEND Study Results, and Expansion into Asian Markets
markets.businessinsider.com - October 2 at 9:36 AM
finanznachrichten.de logoINVENTIVA: Inventiva reports its 2023 first-half financial results and provides a corporate update
finanznachrichten.de - September 28 at 6:58 PM
finance.yahoo.com logoInventiva reports its 2023 first-half financial results and provides a corporate update
finance.yahoo.com - September 28 at 6:58 PM
marketbeat.com logoInventiva (IVA) to Release Quarterly Earnings on Thursday
marketbeat.com - September 22 at 8:50 AM
markets.businessinsider.com logoInvestors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease
markets.businessinsider.com - September 21 at 7:08 PM
markets.businessinsider.com logoPre-market Movers: MURF, IFRX, NEPT, UPTD, AEHL…
markets.businessinsider.com - September 21 at 8:24 AM
marketwatch.com logoInventiva ADRs Rise 9% Following Licensing Deal
marketwatch.com - September 20 at 7:02 PM
finance.yahoo.com logoInventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea
finance.yahoo.com - September 20 at 7:02 PM
finance.yahoo.com logoInventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea
finance.yahoo.com - September 20 at 7:02 PM
marketbeat.com logoShort Interest in Inventiva S.A. (NASDAQ:IVA) Rises By 12.6%
marketbeat.com - September 19 at 5:41 AM
msn.com logoIndustry slow to embrace new fatty liver disease nomenclature
msn.com - September 12 at 4:46 PM
marketbeat.com logoInventiva (NASDAQ:IVA) Earns Buy Rating from Guggenheim
marketbeat.com - September 1 at 4:40 PM
msn.com logourban-gro announces sale of investment for proceeds of $2.3 million
msn.com - August 31 at 7:28 PM
msn.com logoInventiva announced €35.7M funding, eyes future raise to meet obligations
msn.com - August 31 at 7:28 PM
finance.yahoo.com logoInventiva announces a financing of approximately €35.7 million from new and existing investors, consisting of a €30.6 million reserved capital increase and a €5.1 million issuance of royalty certificates
finance.yahoo.com - August 31 at 2:31 AM
Get Inventiva News Delivered to You Automatically

Sign up to receive the latest news and ratings for IVA and its competitors with MarketBeat's FREE daily newsletter.



IVA Media Mentions By Week

IVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IVA
News Sentiment

1.05

0.64

Average
Medical
News Sentiment

IVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IVA Articles
This Week

3

2

IVA Articles
Average Week

Get Inventiva News Delivered to You Automatically

Sign up to receive the latest news and ratings for IVA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:IVA) was last updated on 3/2/2024 by MarketBeat.com Staff